Stage III Endometrial Cancer
Oncology
Prevalence
58.0 / 100K
Incidence
28.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Stage III Endometrial Cancer?
There are 1 clinical trial targeting Stage III Endometrial Cancer tracked by BioSniper.
What is the prevalence of Stage III Endometrial Cancer?
The estimated prevalence of Stage III Endometrial Cancer is approximately 58.0 per 100,000 population.
Deep-dive into Stage III Endometrial Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis